NCT03760809View on ClinicalTrials.gov

Dexmedetomidine Combined With Hydromorphone in Tonsillectomy and Adenoidectomy

PHASE4CompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

January 4, 2019

Primary Completion Date

February 10, 2019

Study Completion Date

April 1, 2019

Conditions
Agitated; State, Acute Reaction to Stress
Interventions
DRUG

Dexmedetomidine 0.5μg／kg

Group A received dexmedetomidine 0.5μg／kg (diluted to 100ml，influded in 5 mins at the beginning of the surgery) and hydromophine 0.03 mg／kg as a bolus.

DRUG

Dexmedetomidine 1μg／kg

Group B received dexmedetomidine 1μg／kg (diluted to 100ml，influded in 5 mins at the beginning of the surgery) and hydromophine 0.03 mg／kg as a bolus.

Trial Locations (1)

200031

Anesthesiology Department of Affiliated Eye and ENT Hospital, Fudan University, Shanghai

All Listed Sponsors
lead

Eye & ENT Hospital of Fudan University

OTHER

NCT03760809 - Dexmedetomidine Combined With Hydromorphone in Tonsillectomy and Adenoidectomy | Biotech Hunter | Biotech Hunter